Condition
Hepotacellular Carcinoma
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 1 (1)
Trial Status
Recruiting2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07344116Not Yet RecruitingPrimary
Hepatobiliary and Pancreatic Tumor Biobank
NCT07282184Phase 1RecruitingPrimary
Multimodal Deep Learning for Postoperative Liver Cancer Risk Stratification and Intervention
NCT07147335Recruiting
The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients
Showing all 3 trials